[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 17, 2007

Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(3):261-263. doi:10.1001/jama.297.3.263-a

In Reply: In response to Dr Bhala and colleagues, the definition of major bleeding that we used is standard for studies of VTE, and we believe that blood loss equivalent to 2 units is clinically important.1 Bleeding that was considered abnormal (ie, more than trivial) but that did not satisfy criteria for major bleeding was classified as “minor.” Intracranial and fatal bleeds were described in the article; the remaining major bleeding episodes were intra-articular (n = 2), genitourinary (n = 1), gastrointestinal (n = 1), and retroperitoneal (n = 1) in the unfractionated heparin group and gastrointestinal (n = 6), intra-articular (n = 2), and from a surgical site (n = 1) in the low-molecular-weight heparin group.

First Page Preview View Large
First page PDF preview
First page PDF preview
×